These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36091001)

  • 1. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis.
    Soliman SA; Stanley S; Vanarsa K; Ismail F; Mok CC; Mohan C
    Front Immunol; 2022; 13():910993. PubMed ID: 36091001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response.
    Kim JW; Baek WY; Jung JY; Kim HA; Lee SW; Suh CH
    Front Immunol; 2024; 15():1369385. PubMed ID: 38915417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology.
    Ding H; Lin C; Cai J; Guo Q; Dai M; Mohan C; Shen N
    Arthritis Res Ther; 2020 May; 22(1):122. PubMed ID: 32460901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities.
    Stanley S; Vanarsa K; Soliman S; Habazi D; Pedroza C; Gidley G; Zhang T; Mohan S; Der E; Suryawanshi H; Tuschl T; Buyon J; Putterman C; Mok CC; Petri M; Saxena R; Mohan C
    Nat Commun; 2020 May; 11(1):2197. PubMed ID: 32366845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
    Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
    Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights.
    Lindblom J; Mohan C; Parodis I
    Curr Opin Rheumatol; 2022 Mar; 34(2):139-149. PubMed ID: 35013077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis.
    Vanarsa K; Soomro S; Zhang T; Strachan B; Pedroza C; Nidhi M; Cicalese P; Gidley C; Dasari S; Mohan S; Thai N; Truong VTT; Jordan N; Saxena R; Putterman C; Petri M; Mohan C
    Ann Rheum Dis; 2020 Oct; 79(10):1349-1361. PubMed ID: 32651195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil gelatinase-associated lipocalin as a biomarker for lupus nephritis.
    Torres-Salido MT; Cortés-Hernández J; Vidal X; Pedrosa A; Vilardell-Tarrés M; Ordi-Ros J
    Nephrol Dial Transplant; 2014 Sep; 29(9):1740-9. PubMed ID: 24711435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
    Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
    Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
    Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
    Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
    Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
    Li Y; Tang C; Vanarsa K; Thai N; Castillo J; Lea GAB; Lee KH; Kim S; Pedroza C; Wu T; Saxena R; Mok CC; Mohan C
    J Autoimmun; 2024 Feb; 143():103165. PubMed ID: 38194790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.
    Xue J; Yang J; Yang L; Zhou S; Ji C; Wang X; Yu N; Liu X; Chi S
    J Immunol Res; 2017; 2017():6861575. PubMed ID: 28373995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
    Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
    Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
    Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.